Literature DB >> 32783987

Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.

Pulok K Mukherjee1, Subhadip Banerjee2, Sayan Biswas3, Bhaskar Das4, Amit Kar5, C K Katiyar6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Withania somnifera (L.) Dunal, commonly known as Ashwagandha, is an important medicinal plant that has been used in Ayurvedic and indigenous medicine for more than 3000 years. According to Charaka Samhita, Susruta Samhita and other ancient texts, Ashwagandha is known as Balya (increases strength), Brusya (sexual performance enhancer), vajikari (spermatogenic), Kamarupini (libido-enhancing), Pustida (nourishing). AIM OF THE REVIEW: This review article documented and critically assessed W. somnifera regarding its ethnopharmacology, traditional use, botanical description, phytochemicals present, pharmacological activities, clinical trials, and marketed formulations.
MATERIALS AND METHODS: The sources of information used in the study are traditional Ayurvedic books like Charaka Samhita, Susruta Samhita, Astanga Hridaya etc, government reports, dissertations, books, research articles and databases like Science-Direct, SciFinder, Web of Science, PubMed, Wiley Online Library, and ACS Publications on Ashwagandha and Withania somnifera (L.) Dunal.
RESULTS: Traditional uses of Ashwagandha in Ayurveda are very prominent in several texts where formulations with various dosage forms have been mentioned in Charaka Samhita, Susruta Samhita, Astanga Hridaya, different nighantus etc. The drugs were identified based on their composition containing Ashwagandha as one of the major ingredients and their medicinal uses. Phytochemical studies on W. somnifera revealed the presence of important chemical constituents such as flavonoids, phenolic acids, alkaloids, saponins, tannins, and withanolides. The phytochemicals showed various pharmacological activities like anti-cancer, immunomodulatory, cardioprotective, neuroprotective, anti-aging, anti-stress/adaptogenic and anti-diabetic. Various clinical trials show that the plant extract and its bioactive compounds are used in the prevention and treatment of many diseases, such as arthritis, impotence, amnesia, anxiety, cancer, neurodegenerative and cardiovascular diseases, and others.
CONCLUSIONS: Pharmacological data reviewed here revealed that W. somnifera is a potential source for the treatment of a wide range of diseases especially anxiety and other CNS disorders. From its ancient use to its modern application it has been proven to be non-toxic and effective clinically for human health and wellness. W. somnifera based herbal formulation has been marketed in the form of supplement, extract, capsule, powder etc. This review will be helpful to correlate the mechanism of action with the phytochemical profile of this well-known plant from Ayurveda.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Ayurveda; Clinical trial; Phytochemistry pharmacology; Solanaceae; Withania somnifera (L.) dunal

Mesh:

Substances:

Year:  2020        PMID: 32783987     DOI: 10.1016/j.jep.2020.113157

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  9 in total

Review 1.  The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.

Authors:  John E Lewis; Jillian Poles; Delaney P Shaw; Elisa Karhu; Sher Ali Khan; Annabel E Lyons; Susana Barreiro Sacco; H Reginald McDaniel
Journal:  J Clin Transl Res       Date:  2021-08-04

2.  Combination of Ashwagandha Water Extract and Intermittent Fasting as a Therapy to Overcome Cisplatin Resistance in Breast Cancer: An in vitro and in vivo Study.

Authors:  Sajidah Jawarneh; Wamidh H Talib
Journal:  Front Nutr       Date:  2022-07-04

3.  Sodium-calcium exchanger isoform-3 targeted Withania somnifera (L.) Dunal therapeutic intervention ameliorates cognition in the 5xFAD mouse model of Alzheimer's disease.

Authors:  Henok Kessete Afewerky; Hao Li; Tongmei Zhang; Xinyan Li; Yacoubou Abdoul Razak Mahaman; Limin Duan; Pengwei Qin; Jiequn Zheng; Lei Pei; Youming Lu
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

4.  Withania somnifera (L.) Dunal whole-plant extract demonstrates acceptable non-clinical safety in rat 28-day subacute toxicity evaluation under GLP-compliance.

Authors:  Acharya Balkrishna; Sandeep Sinha; Jyotish Srivastava; Anurag Varshney
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

5.  Effects of Acute Ashwagandha Ingestion on Cognitive Function.

Authors:  Dante Xing; Choongsung Yoo; Drew Gonzalez; Victoria Jenkins; Kay Nottingham; Broderick Dickerson; Megan Leonard; Joungbo Ko; Mark Faries; Wesley Kephart; Martin Purpura; Ralf Jäger; Ryan Sowinski; Christopher J Rasmussen; Richard B Kreider
Journal:  Int J Environ Res Public Health       Date:  2022-09-20       Impact factor: 4.614

6.  Withania somnifera Extracts Promote Resilience against Age-Related and Stress-Induced Behavioral Phenotypes in Drosophila melanogaster; a Possible Role of Other Compounds besides Withanolides.

Authors:  Helen Holvoet; Dani M Long; Alexander Law; Christine McClure; Jaewoo Choi; Liping Yang; Luke Marney; Burkhard Poeck; Roland Strauss; Jan F Stevens; Claudia S Maier; Amala Soumyanath; Doris Kretzschmar
Journal:  Nutrients       Date:  2022-09-22       Impact factor: 6.706

7.  DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of Withania somnifera (Ashwagandha).

Authors:  Shazia Siddiqui; Nabeel Ahmed; Mausumi Goswami; Anindita Chakrabarty; Goutam Chowdhury
Journal:  Curr Res Toxicol       Date:  2021-02-16

8.  Withania somnifera and Centella asiatica Extracts Ameliorate Behavioral Deficits in an In Vivo Drosophila melanogaster Model of Oxidative Stress.

Authors:  Kadine Cabey; Dani M Long; Alexander Law; Nora E Gray; Christine McClure; Maya Caruso; Parnian Lak; Kirsten M Wright; Jan F Stevens; Claudia S Maier; Amala Soumyanath; Doris Kretzschmar
Journal:  Antioxidants (Basel)       Date:  2022-01-06

Review 9.  Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia.

Authors:  Alex B Speers; Kadine A Cabey; Amala Soumyanath; Kirsten M Wright
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.